Clinical and Molecular Characteristics of Chinese Patients With X-Linked Lymphoproliferative Syndrome Type 1

被引:7
|
作者
An, Yun-Fei [1 ,2 ]
Luo, Xiao-Bo [1 ]
Yang, Xi [1 ]
Wang, Jing [1 ]
Li, Li [1 ]
Zhao, Xiao-Dong [1 ,2 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Key Lab Child Dev & Disorders, Minist Educ, Chongqing 400014, Peoples R China
[2] Chongqing Med Univ, Childrens Hosp, Div Immunol, Chongqing 400014, Peoples R China
基金
中国国家自然科学基金;
关键词
mild clinical phenotype; primary immunodeficiency; residual SAP expression; X-linked lymphoproliferative syndrome; BARR-VIRUS INFECTION; DISEASE GENE; LYMPHOCYTIC VASCULITIS; SH2D1A; SAP; IMMUNODEFICIENCY; DEFICIENCY; FAMILY; MUTATIONS; RESPONSES;
D O I
10.1002/pbc.25126
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundX-linked lymphoproliferative syndrome type 1 (XLP1) is a rare inherited, life-threatening immunodeficiency disorder caused by mutations in SH2D1A gene. It affect approximately two to three males per million. Fewer than 10 cases with definite gene mutations have been reported in Chinese mainland and no rapid diagnosis method has been established. ProcedureWe determined the clinical and molecular characteristics of five patients with XLP1. The SH2D1A gene were amplified by PCR and sequenced, the SAP expression was analyzed by flow cytometry. ResultsTwo patients had novel SH2D1A mutations and three had mutations that have been previously reported. Three patients presented with fulminant infectious mononucleosis or hemophagocytic lymphohistiocytosis and one presented with lymphoma. Null or decreased SAP expression on PBMCs was noted. The remaining patient presented with unique, recurrent, nonfulminant infectious mononucleosis and bimodal intracellular SAP protein expression. ConclusionsThe overall molecular characteristics and clinical phenotypes of Chinese patients with XLP1 matched previous reports. The unique bimodal intracellular SAP protein expression indicated the presence of some residual SAP-positive T cells that are able to respond to persistent Epstein-Barr virus infection and could explain the relatively mild clinical phenotype of this patient. Pediatr Blood Cancer 2014;61:2043-2047. (c) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:2043 / 2047
页数:5
相关论文
共 50 条
  • [41] Unusual CNS complications in X-linked lymphoproliferative syndrome
    Oswalt, M. L.
    Kemp, S. F.
    Yates, A. B.
    Roy, S. R.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A73 - A73
  • [42] CYTOGENETIC STUDIES OF X-LINKED LYMPHOPROLIFERATIVE SYNDROME(XLP)
    BARNABEI, VM
    SAKAMOTO, K
    SEELEY, JK
    PURTILO, DT
    AMERICAN JOURNAL OF HUMAN GENETICS, 1981, 33 (06) : A98 - A98
  • [43] Cellular and molecular pathogenesis of X-linked lymphoproliferative disease
    Moretta, Alessandro
    Bottino, Cristina
    Parolini, Silvia
    Moretta, Lorenzo
    Biassoni, Roberto
    Notarangelo, Luigi D.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 1 (06) : 513 - 517
  • [44] X-linked Inhibitor of Apoptosis Protein Deficiency: More than an X-linked Lymphoproliferative Syndrome
    Aguilar, Claire
    Latour, Sylvain
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (04) : 331 - 338
  • [45] Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia
    Aghamohammadi, Asghar
    Fiorini, Maurilia
    Moin, Mostafa
    Parvaneh, Nima
    Teimourian, Shahram
    Yeganeh, Mehdi
    Goffi, Francesca
    Kanegane, Hirokazu
    Amirzargar, Ali Akbar
    Pourpak, Zahra
    Rezaei, Nima
    Salavati, Ali
    Pouladi, Nima
    Abdollahzade, Sina
    Notarangelo, Luigi D.
    Miyawaki, Toshio
    Plebani, Alessandro
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2006, 141 (04) : 408 - 414
  • [46] Molecular and cellular pathogenesis of X-linked lymphoproliferative disease
    Nichols, KE
    Ma, CS
    Cannons, JL
    Schwartzberg, PL
    Tangye, SG
    IMMUNOLOGICAL REVIEWS, 2005, 203 : 180 - 199
  • [47] Molecular and immunological basis of X-linked lymphoproliferative disease
    Latour, S
    Veillette, A
    IMMUNOLOGICAL REVIEWS, 2003, 192 (01) : 212 - 224
  • [48] A novel pathogenic SH2D1A mutation for X-linked lymphoproliferative syndrome type 1
    Feteih, Abeer
    Alkhammash, Salma
    Zavalkoff, Samara
    Mitchell, David
    Noya, Francisco
    McCusker, Christine
    CLINICAL IMMUNOLOGY, 2020, 219
  • [49] The importance of early detection in x-linked lymphoproliferative syndrome type 1: the story of three family members
    Brewington, S. E.
    Valdin, H. L.
    Yu, L.
    LeBlanc, Z.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S197 - S198
  • [50] X-LINKED LYMPHOPROLIFERATIVE DISEASE
    SEEMAYER, TA
    GRIERSON, H
    PIRRUCCELLO, SJ
    GROSS, TG
    WEISENBURGER, DD
    DAVIS, J
    SPIEGEL, K
    BRICHACEK, B
    SUMEGI, J
    AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1993, 147 (11): : 1242 - 1245